199 related articles for article (PubMed ID: 7392308)
21. [Fundamental and clinical studies of bone scintigraphy with 99mTc-MDP (methylene diphosphonate) (author's transl)].
Miyamae T; Kan M; Seki M; Nakagawa H
Radioisotopes; 1977 Nov; 26(11):807-9. PubMed ID: 202998
[No Abstract] [Full Text] [Related]
22. [Evaluations of clinical usefulness of bone and tumor scintigraphy in neuroblastomas: detection of extraosseous lesions (author's transl)].
Miyoshi M; Oshiumi Y; Kamoi I; Ichiya Y; Nishitani H; Matsuura K; Jo K; Ono Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1980 May; 40(5):458-65. PubMed ID: 7422473
[No Abstract] [Full Text] [Related]
23. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
[TBL] [Abstract][Full Text] [Related]
24. [A new bone scanning agent: clinical experience of 99mTc-hydroxymethane diphosphonate (HMDP) (author's transl)].
Fukunaga M; Fujita T; Shigeno C; Morita R; Torizuka K
Kaku Igaku; 1981 Jul; 18(6):863-7. PubMed ID: 7311135
[No Abstract] [Full Text] [Related]
25. [An evaluation of the 99mTc-Sn-polyphosphate or 99mTc-Sn-pyrophosphate scintigraphy for the detection of bone metastases from prostatic carcinoma (author's transl)].
Miki M; Machida T; Irikura H; Ueda M; Kido A
Nihon Hinyokika Gakkai Zasshi; 1974 Mar; 65(3):147-57. PubMed ID: 4369483
[No Abstract] [Full Text] [Related]
26. [Four cases of diffuse bone metastasis with increased uptake in 99mTc-MDP bone scintigraphy].
Dannoura R; Morita S; Kikuchi S; Ohta M; Ohtake H
Kaku Igaku; 1984 Nov; 21(11):1521-5. PubMed ID: 6241644
[No Abstract] [Full Text] [Related]
27. [Clinical evaluation of bone scan using Tc-99m methylene diphosphonate (author's transl)].
Kado B; Nakajima T; Sakura M; Sasaki Y; Nagai T
Kaku Igaku; 1979 Feb; 16(1):95-103. PubMed ID: 439497
[No Abstract] [Full Text] [Related]
28. Recognition of the superscan in prostatic bone scintigraphy.
Constable AR; Cranage RW
Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
[TBL] [Abstract][Full Text] [Related]
29. [Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase (PAP) in blood by PAP RIA kit "EIKEN" (author's transl)].
Kida T; Higuchi Y
Kaku Igaku; 1981 Aug; 18(7):907-15. PubMed ID: 7321322
[No Abstract] [Full Text] [Related]
30. [Clinical evaluation of "cold" lesion on bone scintigraphy: concerning metastatic bone tumour (author's transl)].
Bussaka H; Fujimura N
Kaku Igaku; 1980 Sep; 17(8):901-9. PubMed ID: 7218586
[No Abstract] [Full Text] [Related]
31. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760
[TBL] [Abstract][Full Text] [Related]
32. [Bone scintigraphy--abnormal RI accumulation in soft tissue metastasis from osteosarcoma with 99Tc-MDP (author's transl)].
Suzuki M; Kato T; Imaeda T; Doi H
Rinsho Hoshasen; 1979 Jan; 24(1):171-2. PubMed ID: 283256
[No Abstract] [Full Text] [Related]
33. [Changes of bone scintigraphy and CT scan in metastatic bone tumors after radiotherapy with Co-60 (author's transl)].
Sakata T; Yamasaki K; Kawai T; Maeda H; Okahashi S; Suezawa Y; Arai M; Akagi H
Kaku Igaku; 1980 Jul; 17(5):565-73. PubMed ID: 7420762
[No Abstract] [Full Text] [Related]
34. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
35. [Cancer of the prostate: value of bone scintigraphy. Point of view].
Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
[TBL] [Abstract][Full Text] [Related]
36. [131I-MIBG scintigraphy for the detection of metastatic lesions from malignant pheochromocytoma--comparison of 131I-MIBG scintigraphy with 99mTc-MDP bone scintigraphy in detecting bone metastases].
Ozawa N; Imaeda T; Seki M; Koike S
Kaku Igaku; 1988 Jan; 25(1):97-103. PubMed ID: 3373813
[No Abstract] [Full Text] [Related]
37. [Clinical evaluation of 201Tl-chloride scintigraphy for bone lesions (author's transl)].
Shishido F; Tsuya A; Ko S; Tokumoto Y; Tateno Y; Uchida I; Kawaguchi T; Wada N; Matsumoto S; Umegaki Y
Kaku Igaku; 1981 May; 18(4):455-62. PubMed ID: 7289211
[No Abstract] [Full Text] [Related]
38. [Clinical evaluation of bone scintigraphy in patients with prostatic cancer].
Murai N; Jinnouchi S; Hoshi H; Watanabe K; Shinkawa T
Kaku Igaku; 1986 Feb; 23(2):115-22. PubMed ID: 3712853
[No Abstract] [Full Text] [Related]
39. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy].
Matsuda H; Sakashita S; Arakawa M; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173
[No Abstract] [Full Text] [Related]
40. Normal technetium 99m diphosphonate bone scintigraphy in skeletal metastases from hepatocellular carcinoma.
Maillefert JF; Tebib J; Quipourt V; Brunotte F; Michiels C; Hillon P; Tavernier C
J Hepatol; 1994 Oct; 21(4):684. PubMed ID: 7814817
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
